Wolf A, et al. - Researchers examined racial disparities in early-stage lung cancer treatment, adjusting for clinicodemographic factors using the Surveillance, Epidemiology, and End Results-Medicare dataset. They identified 22,724 patients who were diagnosed with primary stage I non–small cell lung cancer between 1992 and 2009; 21,230 (93.4%) white and 1494 (6.6%) black. Findings exhibit persistence of treatment disparities even when adjusting for clinical and demographic factors. Black patients less frequently received treatment and less frequently received surgery only when treated. Despite reporting worse survival in black patients, no difference in survival was evident when accounting for treatment mode.